Abstract
Angina pectoris is usually considered a consequence of flow-limiting epicardial coronary artery disease (CAD), which impairs myocardial blood flow and results in myocardial ischaemia (i.e. ischaemic heart disease, IHD). In clinical practice, the diagnostic management of patients with angina centres on the detection of obstructive epicardial CAD, and the treatment involves optimal medical therapy and consideration of myocardial revascularisation using percutaneous coronary intervention or coronary artery bypass grafting. This clinical paradigm fails to account for the considerable proportion of patients with angina in whom obstructive epicardial disease is excluded (i.e. angina and nonobstructive coronary artery disease, ANOCA). This common scenario presents a diagnostic conundrum. Stable coronary syndrome (SCS) is a term which subtends a clinically relevant classification that fully encompasses the different diseases of the epicardial and microvascular coronary circulation. In this chapter, we describe the causes of angina based on the underlying coronary vascular pathophysiology and discuss the diagnostic and therapeutic approaches to patients with angina secondary to disorders of coronary vascular dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003. https://doi.org/10.1093/eurheartj/eht296.
Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–95. https://doi.org/10.1056/NEJMoa0907272.
Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart. 2018;104(4):284–92. https://doi.org/10.1136/heartjnl-2017-311446.
Pries AR, Badimon L, Bugiardini R, et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J. 2015;36(45):3134–46. https://doi.org/10.1093/eurheartj/ehv100.
Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830–40. https://doi.org/10.1056/NEJMra061889.
Lee JM, Jung JH, Hwang D, et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol. 2016;67(10):1158–69. https://doi.org/10.1016/j.jacc.2015.12.053.
Berry C. Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease. Circulation. 2017;136(5):437–9. https://doi.org/10.1161/CIRCULATIONAHA.117.028991.
Crea F, Lanza GA. Treatment of microvascular angina: the need for precision medicine. Eur Heart J. 2016;37(19):1514–6. https://doi.org/10.1093/eurheartj/ehw021.
Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135(11):1075–92. https://doi.org/10.1161/CIRCULATIONAHA.116.024534.
Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16–20. https://doi.org/10.1016/j.ijcard.2017.08.068.
Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol. 2012;52(4):857–64. https://doi.org/10.1016/j.yjmcc.2011.08.028.
Duncker DJ, Koller A, Merkus D, et al. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis. 2015;57(5):409–22. https://doi.org/10.1016/j.pcad.2014.12.002.
Ong P, Athanasiadis A, Borgulya G, et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655–62. https://doi.org/10.1016/j.jacc.2011.11.015.
Hsu LY, Jacobs M, Benovoy M, et al. Diagnostic performance of fully automated pixel-wise quantitative myocardial perfusion imaging by cardiovascular magnetic resonance. J Am Coll Cardiol Img. 2018;11(5):697–707. https://doi.org/10.1016/j.jcmg.2018.01.005.
Members ETF. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003. https://doi.org/10.1093/eurheartj/eht296.
Lee BK, Lim HS, Fearon WF, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054–60. https://doi.org/10.1161/CIRCULATIONAHA.114.012636.
Echavarria-Pinto M, van de Hoef TP, Serruys PW, et al. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation. Curr Opin Cardiol. 2014;29(6):564–70. https://doi.org/10.1097/HCO.0000000000000110.
Sheikh AR WJ, Bariey Merz N, Beltrame JF. The current state of invasive coronary evaluation and management of patients with angina and nonobstructive coronary arteries: American College of Cardiology; 2016 [Expert Analysis]. Available from: http://www.acc.org/latest-in-cardiology/articles/2016/05/26/08/31/the-current-state-of-invasive-coronary-evaluation-and-management-of-patients-with-angina-and-nonobstructive-coronary-arteries?w_nav=LC. Accessed 20 July 2017.
Ong P, Athanasiadis A, Borgulya G, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation. 2014;129(17):1723–30. https://doi.org/10.1161/CIRCULATIONAHA.113.004096.
Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: CorMicA trial. J Am Coll Cardiol. 2018. https://doi.org/10.1016/j.jacc.2018.09.006.
Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. https://doi.org/10.1186/1532-429X-15-35.
Marinescu MA, Loffler AI, Ouellette M, et al. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. J Am Coll Cardiol Img. 2015;8(2):210–20. https://doi.org/10.1016/j.jcmg.2014.12.008.
Ford TJ, Rocchiccioli P, Good R, et al. Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur Heart J. 2018. https://doi.org/10.1093/eurheartj/ehy529.
Mohri M, Shimokawa H, Hirakawa Y, et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol. 2003;41(1):15–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Corcoran, D., Ford, T.J., Berry, C. (2019). Stable Coronary Syndromes. In: Touyz, R., Delles, C. (eds) Textbook of Vascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-16481-2_35
Download citation
DOI: https://doi.org/10.1007/978-3-030-16481-2_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16480-5
Online ISBN: 978-3-030-16481-2
eBook Packages: MedicineMedicine (R0)